Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
CMS Physics : Technical Design Report Volume 1: Detector Performance and Software
- G. Bayatian, A. Korablev, P. Avery
- Physics
- 2006
Polycyclic aromatic hydrocarbons in the diet.
- D. Phillips
- Environmental ScienceMutation research
- 15 July 1999
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
- S. Zienolddiny, D. Campa, A. Haugen
- BiologyCarcinogenesis
- 1 March 2006
TLDR
Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
- E. Miller, A. Swanson, D. Phillips, T. Fletcher, A. Liem, J. Miller
- Chemistry, BiologyCancer research
- 1 March 1983
TLDR
Mutational signatures associated with tobacco smoking in human cancer
- L. Alexandrov, Y. S. Ju, M. Stratton
- Biology, MedicineScience
- 4 November 2016
TLDR
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
TLDR
32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
- D. Phillips, M. V. Reddy, K. Randerath
- Biology, MedicineCarcinogenesis
- 1 December 1984
TLDR
Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols.
- D. Phillips, M. Castegnaro
- BiologyMutagenesis
- 1 May 1999
TLDR
Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
- D. Eastmond, A. Hartwig, C. Vickers
- BiologyMutagenesis
- 1 July 2009
Since the publication of the International Programme on Chemical Safety (IPCS) Harmonized Scheme for Mutagenicity Testing, there have been a number of publications addressing test strategies for…
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk.
TLDR
...
1
2
3
4
5
...